Details for New Drug Application (NDA): 202561
✉ Email this page to a colleague
The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
Summary for 202561
Tradename: | CHLOROTHIAZIDE SODIUM |
Applicant: | Am Regent |
Ingredient: | chlorothiazide sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202561
Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 202561
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202561 | ANDA | American Regent, Inc. | 0517-1820 | 0517-1820-01 | 1 VIAL in 1 CARTON (0517-1820-01) / 18 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Apr 22, 2013 | TE: | AP | RLD: | No |
Complete Access Available with Subscription